Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis
- 8 April 2020
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (2), 2000175
- https://doi.org/10.1183/13993003.00175-2020
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- An investigation into biomarkers for the diagnosis of ABPA and aspergillus disease in cystic fibrosisPediatric Pulmonology, 2019
- Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthmaJournal of Cystic Fibrosis, 2016
- Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta‐analysisClinical & Experimental Allergy, 2015
- Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equationsEuropean Respiratory Journal, 2012
- Coming together: the ATS/ERS consensus on clinical pulmonary function testingEuropean Respiratory Journal, 2005
- Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus ConferenceClinical Infectious Diseases, 2003
- Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological studyEuropean Respiratory Journal, 2000
- Allergic Bronchopulmonary Aspergillosis in Cystic FibrosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1999
- Clinical and Immunologic Criteria for the Diagnosis of Allergic Bronchopulmonary AspergillosisAnnals of Internal Medicine, 1977